CVS Caremark has been ordered to pay $95m (which could rise to $285m if treble damages are imposed) after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy discounts, violating the False Claims Act.
The ruling follows a